In mice and patients with melanoma following anti-CTLA-4 therapy, T cell responses specific for Bacteroides thetaiotaomicron or Bacteroides fragilis were associated with the efficacy of CTLA-4 blockade [40]. This evidence concerns the gene CTLA4 and melanoma.